Name | Lubiprostone |
---|---|
Synonyms |
Prostan-1-oic acid, 11,15-epoxy-16,16-difluoro-15-hydroxy-9-oxo-, (11α,15R)-
13,14-dihydro-15-keto-16,16-difluoro-Prostaglandin E1 9ALPHA-HYDROXY-11,15-DIOXO-PROST-5Z-EN-1-OIC ACID 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard DK-PGD2 (3aR,4R,5R,6aS)-4-[(1E)-4,4-Difluoro-3-oxo-1-octen-1-yl]-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl 4-biphenylcarboxylate 13,14-dihydro-15-keto-prostaglandin D2 [1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-4-[(1E)-4,4-difluoro-3-oxo-1-octen-1-yl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester 13,14-Dihydro-15-keto-PGD2 7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid 13,14-Dihydro-15-ketoprostadlandin D2 Lubiprostone (11α,15R)-16,16-Difluoro-15-hydroxy-9-oxo-11,15-epoxyprostan-1-oic acid 13,14-dihydro-15-keto PD2 13,14-dihydro-15-keto-16,16-difluoro-PGE1 |
Description | Lubiprostone(SPI-0211;RU0211) is a gastrointestinal agent used for the treatment of idiopathic chronic constipation.Target: OthersLubiprostone is a bicyclic fatty acid derived from prostaglandin E1 that acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements (SBM). From Wikipedia. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 532.3±50.0 °C at 760 mmHg |
Melting Point | 56-59ºC |
Molecular Formula | C20H32F2O5 |
Molecular Weight | 390.462 |
Flash Point | 275.7±30.1 °C |
Exact Mass | 390.221771 |
PSA | 83.83000 |
LogP | 2.85 |
Vapour Pressure | 0.0±3.2 mmHg at 25°C |
Index of Refraction | 1.486 |
Storage condition | -20°C Freezer |
Symbol |
![]() GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
RTECS | UK8257750 |
HS Code | 2918990090 |
~70% 136790-76-6 |
Literature: APOTEX PHARMACHEM INC.; KOTHAKONDA, Kiran, Kumar; WANG, Fan; GUNTOORI, Bhaskar, Reddy; NGUYEN, Minh, T.N.; CECCARELLI, Alfredo, Paul; ZHAO, Yajun; KOTIPALLI, Uma; DUNCAN, Sammy, Chris; MILNEE, Kaarina, K.; KELLS, Kevin, W.; MONTEMAYOR, Laura, Kaye Patent: WO2010/83597 A1, 2010 ; Location in patent: Page/Page column 54-55 ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; Page/Page column 13-14 ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
~% 136790-76-6 |
Literature: WO2011/91513 A1, ; |
Precursor 3 | |
---|---|
DownStream 1 | |
HS Code | 2918990090 |
---|---|
Summary | 2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |